We are a research and production company specializing in animal health products such as veterinary drugs, mixed feed additives, and pre mixed feed additives
language
Equine Osteoarthritis: The Silent Killer of Athletic Horses
Release time:
2026-08-30
What Is Osteoarthritis?
Osteoarthritis (OA) is one of the leading causes of lameness in horses and the single greatest source of economic loss in the equine industry. This disease severely impacts horses' athletic value and welfare, causing substantial economic losses to the horse industry.
Osteoarthritis is a chronic joint disease characterized by degenerative changes in articular cartilage. By definition, OA refers to the degeneration of articular cartilage that lines the ends of bones inside joints. This layer of articular cartilage cushions the bones to dissipate concussive forces as the horse moves, permitting smooth, frictionless motion. Modern veterinary research recognizes OA as a whole joint disease—also affecting the subchondral bone, synovial membrane, joint capsule, supporting ligaments, and other structures.
How Prevalent Is It?
Osteoarthritis is extremely common in horses:
OA is the most common cause of lameness in horses, responsible for approximately 60% of lameness cases.
The prevalence of OA exceeds 50% in horses older than 15 years and reaches 80%–90% in horses over 30.
This is not an "old horse disease"—it commonly occurs in young, active performance horses. "Almost all performance horses will inevitably suffer from a certain degree of OA".
In one study, osteoarthrosis accounted for 32.27% of all disorders in horses.
Clinical Signs
OA can affect any joint, and clinical signs vary greatly depending on which joint is affected. Common presentations include:
1.Lameness: Chronic, slowly progressive—the primary clinical sign
2.Poor or changed performance: Declining athletic performance, reluctance to work
3.Behavioral changes: Reluctance or slow to lie down or rise
4.Stiffness: May improve with exercise
5.Reduced range of motion in joints
6.Uneven muscle development
7.Heat, pain, and swelling in the joint
Economic Impact
The economic burden of osteoarthritis on the equine industry is immense:
Estimated annual costs can reach $10,000–15,000 per horse for diagnosis, treatment, and medication.
The market value of a horse affected by osteoarthritis decreases substantially.
OA accounts for the greatest single economic loss to the horse industry, with an estimated cost of up to $15,000 per year per horse.
The global equine osteoarthritis therapeutics market was valued at **$1.8 billion** in 2025 and is expected to reach $3.1 billion by 2034.
The veterinary nutritional supplement industry earns $2 billion annually, with more than half coming from the equine sector.
Conventional Treatment Options
Currently, there is no cure for equine osteoarthritis; treatment focuses on symptomatic management:
(a) NSAIDs: Such as phenylbutazone, providing analgesia
(b) Intra-articular injections: Corticosteroids are the most commonly used intra-articular anti-inflammatories
(c) Arthroscopic debridement and lavage
(d) Rehabilitation and exercise management
While effective, these approaches are expensive and cannot halt disease progression.
Nutritional Management: A Critical Defense Line for Joint Health
Beyond drugs and surgery, joint nutritional supplementation is becoming an increasingly important component of comprehensive equine osteoarthritis management. Oral joint supplements—particularly those containing glucosamine—are among the most popular feed additives used by horse owners. Studies have shown that oral glucosamine hydrochloride and chondroitin sulfate supplements can provide symptomatic relief for veteran horses, evidenced by improved stride characteristics.
Latest updates
FOLLOW US
ENQUIRY NOW
* Note: Please be sure to fill in the information accurately, we will contact you as soon as possible